Chapter 6 PUBH

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/17

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

18 Terms

1
New cards

noncommunicable diseases

chronic conditions that do not result from infections processes and are not communicable

2
New cards

epidemiological transition

a historical shift in the patterns of disease and mortality in a population, typically from infectious diseases to chronic diseases

3
New cards

screening

the use of tests on people who don’t have symptoms of a specific disease

4
New cards

lead time bias

early detection of a disease without an improved outcome

5
New cards

Rayes Theorem 

math formula that interprets the meaning of diagnostic and screening tests. It provides a connection between the probability of disease before a test is conditioned, and the probability of disease after knowing whether the test results are positive or negative 

6
New cards

pretest of probability of disease

probability of disease before a test is conduction

7
New cards

posttest probability of disease

probability of disease after knowing whether the results are positive or negative

8
New cards

sensitivity

probability that the test will be positive in the presence of disease

9
New cards

specificity 

probability that the test will be negative in the absence of disease

10
New cards

sequential testing

an initial screening is followed by a definite/diagnostic test

11
New cards

multiple risk factor deduction

addressing multiple interconnected risk factors simultaneously to prevent disease and promote well-being

12
New cards

cost effectiveness

combines issues of benefits and harms with issues of financial costs. considers the benefits and harms of an intervention to determine its net effectiveness

13
New cards

incremental cost effectiveness

ratio that represents the additional cost relative to the additional net effectiveness

14
New cards

quality adjusted life year

the number of life years saved by an intervention

15
New cards

predictive genetic testing

identifies gene mutations that increase an individuals risk of developing a disease

16
New cards

incomplete penetrance

limited ability to use predictive testing

17
New cards

carrier tests

genetic tests that identify if a person has gene mutations for certain genetic disorders, even though they don't have symptoms themselves

18
New cards

determinants of disease

communicable, noncommunicable, and environmental disease and injuries